The notion that health spending growth in the United States is slowing, perhaps permanently, is becoming an increasing topic among policymakers. The most recent issue of Health Affairs is devoted largely to health costs and one article discusses the possible implications of a longer-lasting reduction of the rate of growth. (HA Article) For government spending, forecasting the rate of growth is critical and CMS and CBO have reduced near-term forecasts for spending increases, largely because of the slowness of economic growth. If the slowing rate of growth extended for longer, the authors believe that spending could be $770 billion lower than currently believed. The authors find a close correlation between income growth, national GDP growth and health spending and suggest that the recession accounted for about 37% of the spending growth slowdown. Other contributors were differences in payers, primarily a shift to more Medicare and Medicaid, which determine prices by fiat or political wrangling, and Medicare reimbursement changes. However, about 55% is unexplained, which leaves everyone wondering if something more permanent has changed in health utilization or pricing. If the economy does return to more robust growth, according to most models, health spending will increase at least proportionately, if not more. Other factors may also be more one-time, as opposed to ongoing changes that permanently lower the growth rate. But maybe Americans are behaving in more healthy ways and are more cautious about running to the doctor. And the effect of cost-shifting in private insurance may not be fully appreciated. And growth in new technologies and treatment methods may have leveled off as well. There certainly are fewer blockbuster drugs. It would be a great boon to public finance if health spending increases are permanently lower, but we simply don’t know that this is the case yet.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Mental health company Headway makes, well, headway, by raising an impressive $125 million round of new capital. The company connects patients with mental health providers and facilitates providers working with...
October 11, 2023
Two health care firms owned by private equity firms are merging in a transaction supposedly valued at $3 billion. HealthComp administers self-funded plans for employers and other groups and Virgin...
September 27, 2023
NextGen, an electronic medical records firm, is being put out of its public company misery, as a PE firm will pay $1.6 billion for the one-time high-flier.
September 7, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace